GloPID-R is a unique international network of major research funding organizations.
Together, we facilitate a rapid and effective response to infectious disease outbreaks.

Our mission

Our Work

Our aim is to invest in research capacity and capabilities to support the rapid initiation of scientific research in case of an outbreak.

Data
Sharing

Discover our work to improve data sharing during public health emergencies.
Read more

Clinical Trial
Networks

Hear from the experts on topics such as social science, data sharing, capacity building, and EARL barriers.
Read more

Ebola
Outbreak

GloPID-R members are reacting to outbreaks occurring throughout the world.
Read more

29 members

Since its creation in 2013, GloPID-R has steadily increased its membership. Today, it consists of 29 members worldwide. The World Health Organization, the Coalition for Epidemic Preparedness Innovations (CEPI) and the European & Developing Countries Clinical Trials Partnership (EDCTP) are also actively engaged in the network.

All members
| News |

Read the latest news on how GloPID-R is investing in infectious disease research and innovation.

Latest news

All news

Global COVID-19 research agenda still missing the priorities of low- and middle-income countries

07/05/2021
An article published today in The Lancet calls for urgent collaboration and coordination for unmet, underfunded COVID-19 research priorities in low-resource settings.   Over...
Read more

Funding opportunity: Four calls for research on coronavirus variants with €123 million earmarked for research and innovation

13/04/2021
To address the growing threat of coronavirus variants, the European Commission has launched four calls for research to complement earlier...
Read more

GloPID-R observer CEPI launches funding call to develop broadly protective coronavirus vaccines

09/04/2021
With the emergence of novel SARS-CoV-2 variants and the threat of future coronavirus outbreaks, GLOPID-R observer the Coalition for Epidemic...
Read more

Resources

GloPID-R publishes funding opportunities related to infectious diseases and shares its expertise through its publications and webinars.

All resources
Funding opportunities
COVID-19

Swiss National Science Foundation – Switzerland

Read more
Funding opportunities
COVID-19

IMI – EU

Read more
Funding opportunities
COVID-19

Federal Ministry of Education and Research – Germany

Read more